🌸 Yeast Infection Antifungal Treatment Simulator

Candida Overgrowth Baseline

Placeholder: normal flora balance disrupted, yeast overgrows.

• 100%: Baseline load (Placeholder unit)
• Yeast: Cell form (Budding form)
• High: Growth rate (Placeholder)
• Day 0: Symptom onset (Placeholder)

Overgrowth dynamics

Placeholder: short note on Candida overgrowth baseline conditions.

Hyphal Form Proliferation

Placeholder: yeast-to-hyphae transition drives tissue invasion.

• ↑↑: Hyphal length (Placeholder)
• High: Invasiveness (Placeholder)
• Forming: Biofilm (Placeholder)
• pH/temp: Trigger (Placeholder)

Hyphal transition

Placeholder: short note on hyphal proliferation mechanism.

Antifungal Drug Mechanism (Ergosterol)

Placeholder: azoles inhibit ergosterol synthesis, weakening membrane.

• 14-DM: Target enzyme (Lanosterol demethylase)
• Ergosterol: Membrane sterol (Placeholder)
• Azole: Drug class (Placeholder)
• Topical/oral: Route (Placeholder)

Ergosterol pathway block

Placeholder: short note on azole ergosterol inhibition mechanism.

Fungal Load Reduction

Placeholder: sustained treatment reduces fungal burden over days.

• Exp. decay: Reduction curve (Placeholder)
• Faster: Oral onset (Placeholder)
• Slower: Topical onset (Placeholder)
• <5%: Target load (Placeholder)

Load decline kinetics

Placeholder: short note on fungal load reduction over treatment.

Symptom Resolution Timeline

Placeholder: symptoms fade as fungal load clears fully.

• 1-3 days: Oral cure (Placeholder)
• 7 days: Topical cure (Placeholder)
• Low-Med: Relapse risk (Placeholder)
• Recommended: Follow-up (Placeholder)

Resolution timeline

Placeholder: short note on symptom resolution timeline.

Placeholder: complete full treatment course to prevent relapse.